Imuran Related Published Studies
Well-designed clinical trials related to Imuran (Azathioprine)
Interferon, azathioprine and corticosteroids in multiple sclerosis: 6-year
follow-up of the ASA cohort. [2012]
A randomized trial of methotrexate versus azathioprine for severe atopic eczema. [2011.08]
A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: the TARGET study. [2011.06]
Steroids and azathioprine in the treatment of IgA nephropathy. [2011.06]
Cyclosporine versus azathioprine therapy in high-risk idiopathic membranous nephropathy patients: A 3-year prospective study. [2011.03]
Comparison of sirolimus with azathioprine in a tacrolimus-based immunosuppressive regimen in lung transplantation. [2011.02.01]
Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial. [2010.12.01]
Infliximab, azathioprine or combination therapy in the treatment of active Crohn's disease. [2010.12]
Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial. [2010.12]
Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy. [2010.10]
Comparison of Sirolimus to Azathioprine in a Tacrolimus Based Immunosuppressive Regimen in Lung Transplantation. [2010.09.10]
Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease. [2010.06.16]
Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial. [2010.06]
Infliximab, azathioprine, or combination therapy for Crohn's disease. [2010.04.15]
The BILAG multi-centre open randomized controlled trial comparing ciclosporin vs azathioprine in patients with severe SLE. [2010.04]
Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease. [2010]
Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease. [2009.10.07]
A pilot study comparing hydrocortisone premedication to concomitant azathioprine treatment in preventing loss of response to infliximab. [2009.09]
Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis. [2009.08]
Safe conversion of mycophenolate mofetil to azathioprine in kidney transplant recipients with sirolimus-based immunosuppression. [2009.04]
Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease. [2009.03]
Azathioprine withdrawal in patients with Crohn's disease maintained on prolonged remission: a high risk of relapse. [2009.01]
Multicentre prospective randomised trial of tacrolimus, azathioprine and prednisolone with or without basiliximab: two-year follow-up data. [2009.01]
Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. [2008.12.25]
Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial. [2008.10]
Azathioprine Withdrawal in Patients With Crohn's Disease Maintained on Prolonged Remission: A High Risk of Relapse. [2008.09.04]
A multicenter, randomized, double-blind trial of everolimus versus azathioprine and placebo to maintain steroid-induced remission in patients with moderate-to-severe active Crohn's disease. [2008.09]
A Multicenter, Randomized, Double-Blind Trial of Everolimus Versus Azathioprine and Placebo to Maintain Steroid-Induced Remission in Patients With Moderate-to-Severe Active Crohn's Disease. [2008.07.30]
Economic evaluation of everolimus and mycophenolate mofetil versus azathioprine in de novo heart transplantation. [2007.12]
A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid. [2007.12]
Comparison of interferon beta products and azathioprine in the treatment of relapsing-remitting multiple sclerosis. [2007.12]
Health-related quality of life and treatment burden in patients with proliferative lupus nephritis treated with cyclophosphamide or azathioprine/ methylprednisolone in a randomized controlled trial. [2007.08]
6-thioguanine nucleotide-adapted azathioprine therapy does not lead to higher remission rates than standard therapy in chronic active crohn disease: results from a randomized, controlled, open trial. [2007.07]
Prospective randomized study of azathioprine vs cyclosporine based therapy in primary haplo-identical living-donor kidney transplantation: 20-year experience. [2007.06]
Mycophenolate Mofetil versus Azathioprine for Prevention of Chronic Allograft Dysfunction in Renal Transplantation: The MYSS Follow-Up Randomized, Controlled Clinical Trial. [2007.06]
A prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine/methylprednisolone. [2007.05]
Randomized study comparing cyclosporine with azathioprine one year after renal transplantation-15-year outcome data. [2007.03.15]
Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis. [2007.03]
Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine. [2007.02]
A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma. [2006.12]
A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus. [2006.11]
Proteinuria following conversion from azathioprine to sirolimus in renal transplant recipients. [2006.10]
A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years. [2006.09]
Tacrolimus/mycophenolate mofetil improved natural killer lymphocyte reconstitution one year after kidney transplant by reference to cyclosporine/azathioprine. [2006.08.27]
Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial. [2006.08]
Comparison of mycophenolate mofetil and azathioprine for prevention of bronchiolitis obliterans syndrome in de novo lung transplant recipients. [2006.04.15]
Infliximab plus azathioprine for steroid-dependent Crohn's disease patients: a randomized placebo-controlled trial. [2006.04]
Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial. [2006.03.11]
A randomized unblinded trial of cyclophosphamide versus azathioprine in the treatment of systemic sclerosis. [2006.03]
Everolimus versus azathioprine in maintenance lung transplant recipients: an international, randomized, double-blind clinical trial. [2006.01]
Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. [2006.01]
The efficacy of combined PUVA and low-dose azathioprine for early and enhanced repigmentation in vitiligo patients. [2006]
Association of inosine triphosphatase 94C>A and thiopurine S-methyltransferase deficiency with adverse events and study drop-outs under azathioprine therapy in a prospective Crohn disease study. [2005.12]
A randomized, double-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine. [2005.06]
Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients. [2005.05]
Intravenous dexamethasone-cyclophosphamide pulse therapy in comparison with oral methylprednisolone-azathioprine therapy in patients with pemphigus: results of a multicenter prospectively randomized study. [2005.03]
Conversion of azathioprine to mycophenolate mofetil and chronic graft failure progression. [2005.03]
Thiopurine methyltransferase enzyme activity determination before treatment of inflammatory bowel disease with azathioprine: effect on cost and adverse events. [2005.03]
Economic evaluation of everolimus vs. azathioprine at one year after de novo heart transplantation. [2005.02]
Maintenance therapies for proliferative lupus nephritis: mycophenolate mofetil, azathioprine and intravenous cyclophosphamide. [2005]
Well-designed clinical trials possibly related to Imuran (Azathioprine)
A randomized, controlled, trial of rituximab for treatment of severe cryoglobulinemic vasculitis. [2011.12.06]
[Treatment of pulmonary fibrosis : New substances and new interventions.] [2011.11.19]
Individually tailored treatment of medication nonadherence. [2011.10]
Impact of de novo everolimus-based immunosuppression on incisional complications in heart transplantation. [2011.09.15]
Anti-TNF agents for Behcet's disease: analysis of published data on 369 patients. [2011.08]
Effect of everolimus introduction on cardiac allograft vasculopathy--results of a randomized, multicenter trial. [2011.07.27]
Long-term results of a randomized controlled trial in childhood IgA nephropathy. [2011.06]
Impact of maintenance immunosuppressive regimens--balance between graft protective suppression of immune functions and a near physiological immune response. [2011.06]
Therapeutic approaches in myositis. [2011.06]
Cyclophosphamide and lupus nephritis: when, how, for how long? [2011.06]
Efficacy and safety of tacrolimus therapy for lupus nephritis: a systematic review of clinical trials. [2011.05]
The influence of immunosuppression switching in liver function in adult hepatic transplantation. [2011.03]
[Bullous pemphigoid: a review]. [2011.03]
Beneficial effects of donor-specific transfusion on renal allograft outcome. [2011.03]
Increased risk of venous thromboembolism with a sirolimus-based immunosuppression regimen in lung transplantation. [2011.02]
Cytomegalovirus risk factors in renal transplantation with modern immunosuppression. [2010.12]
Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis. [2010.10]
Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study. [2010.10]
Rituximab in intractable ocular lesions of Behcet's disease; randomized single-blind control study (pilot study). [2010.08]
Immunosuppressive effects via human intestinal dendritic cells of probiotic bacteria and steroids in the treatment of acute ulcerative colitis. [2010.08]
Treatment of primary Sjogren syndrome: a systematic review. [2010.07.28]
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. [2010.07.15]
Pimecrolimus 1% cream in the treatment of cutaneous lesions of pemphigus vulgaris: a double-blind, placebo-controlled clinical trial. [2010.06]
Comparison of the clinical efficacy of two different immunosuppressive regimens in patients with chronic vogt-koyanagi-harada disease. [2010.06]
Are corticosteroids efficacious for preventing or treating neutralizing antibodies in multiple sclerosis patients treated with beta-interferons? A critically appraised topic. [2010.05]
Long-term cancer risk of immunosuppressive regimens after kidney transplantation. [2010.05]
Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: A prospective randomized study of one hundred twenty-four patients. [2010.04]
Determination of 6-thioguanosine diphosphate and triphosphate and nucleoside diphosphate kinase activity in erythrocytes: novel targets for thiopurine therapy? [2010.04]
Cyclophosphamide and Lupus Nephritis: When, How, For How Long? [2010.01.28]
Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial. [2010.01]
The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide. [2010.01]
Alitretinoin for severe chronic hand Eczema: a NICE single technology appraisal. [2010]
Pimecrolimus 1% cream in the treatment of cutaneous lesions of pemphigus
vulgaris: a double-blind, placebo-controlled clinical trial. [2010]
Long-term graft function with tacrolimus and cyclosporine in renal transplantation: paired kidney analysis. [2009.12]
Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy. [2009.12]
Treatment of severe Henoch-Schonlein nephritis: justifying more immunosuppression. [2009.11]
Lung function in idiopathic pulmonary fibrosis--extended analyses of the IFIGENIA trial. [2009.10.27]
Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. [2009.08]
Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis: a 5-year longitudinal study. [2009.07.15]
Intravenous immunoglobulin as adjuvant therapy for Wegener's granulomatosis. [2009.07.08]
Cyclosporine withdrawal improves long-term graft survival in renal transplantation. [2009.06.27]
|
